FDA inspection
The Procter & Gamble Manufacturing Company: FDA inspection ending Sep 27, 2024
FDA inspection 1252187 · No Action Indicated (NAI) · Iowa City, IA
Key facts
| Inspection ID | 1252187 |
|---|---|
| Firm | The Procter & Gamble Manufacturing Company |
| FEI number | 1913771 |
| Address | 2200 Lower Muscatine Rd |
| City | Iowa City |
| State | IA |
| ZIP | 52240 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Sep 27, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data